Natural products in drug discovery.

By A. Harvey. Drug Discovery Today, 2008

2,012 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Medicinal plants: Past history and future perspective (2017, background): “Currently, it is estimated that over 50% of the available drugs are somehow derived from medicinal plants (30,31).”
Accurate and efficient target prediction using a potency-sensitive influence-relevance voter (2015, positive): “RFs have been applied in chemoinformatics to QSAR/ QSPR modeling, and molecular classification problems [42–44].”
Virtual screening: an endless staircase? (2010, background): “Medicinal chemistry could benefit from computer-assisted natural product analysis by suggested innovative, synthetically feasible scaffolds, extraction of biophoric features and privileged substructure”
Management and Prevention Strategies for Non-communicable Diseases (NCDs) and Their Risk Factors (2020, neutral): “(86, 87) Extract from plants, animals, algae, fungi, or”
Natural products and drug discovery (2009, background): “Nonetheless, the popularity of natural products will continue simply because they are a matchless source of novel drug leads and inspiration for the synthesis of non-natural molecules (Baker et al, 2007; Beghyn et al, 2008; Harvey, 2008; Hunter, 2008; Koehn & Carter, 2005).”
Natural products for cancer chemotherapy (2011, background): “In early 2008, there were 225 natural product-based drugs in various testing procedures such as preclinical, clinical phases I to III, and preregistration (Harvey, 2008).”